Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Radius Residential CareNZSE:RAD +5.68%49 EV-to-EBITDA is 11.09 as of Aug. 17, 2026, which is 1% below its 10-year median of 11.18. GuruFocus rates NZSE:RAD with a GF Score™ of 49/100 and a GF Value™ of NZ$0.29 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 510 Healthcare Providers & Services companies, Radius Residential Care ranks worse than 50.78% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Radius Residential Care's enterprise value is NZ$342.1 Mil.
Radius Residential Care's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$30.9 Mil. Therefore, Radius Residential Care's EV-to-EBITDA for today is 11.09.
The historical rank and industry rank for Radius Residential Care's EV-to-EBITDA or its related term are showing as below:
NZSE:RAD'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.45 Med: 11.18 Max: 26.56
Current: 11.09
During the past 7 years, the highest EV-to-EBITDA of Radius Residential Care was 26.56. The lowest was 9.45. And the median was 11.18.
NZSE:RAD's EV-to-EBITDA is ranked worse than 50.78% of 510
companies
in the Healthcare Providers & Services industry
Industry Median: 10.685
vs NZSE:RAD: 11.09
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Radius Residential Care (NZSE:RAD) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Radius Residential Care's PE Ratio (TTM) for today is calculated as:
Radius Residential Care's share price for today is NZ$0.465.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Radius Residential Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$0.033.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:RAD vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Radius Residential Care's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Radius Residential Care EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Radius Residential Care's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Radius Residential Care's EV-to-EBITDA falls into.
Radius Residential Care's current Enterprise Value is NZ$342.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Radius Residential Care's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$30.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Radius Residential Care (NZSE:RAD) has a EV-to-EBITDA of 11.09 as of Aug. 17, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Radius Residential Care. This is near median its historical median of 11.18. Over the past decade, Radius Residential Care's EV-to-EBITDA has ranged from 9.45 to 26.56. According to the industry distribution chart, Radius Residential Care ranks #259 out of 510 companies in the Healthcare Providers & Services industry, placing it in the top 50.8%.
Is Radius Residential Care's EV-to-EBITDA too high?
Radius Residential Care's current EV-to-EBITDA of 11.09 is near median its 10-year median of 11.18. Over the past 10 years, this metric has ranged from a low of 9.45 to a high of 26.56. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.69. Radius Residential Care's value of 11.09 is 3.8% above this industry median. Based on the distribution chart, Radius Residential Care ranks #259 out of 510 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Radius Residential Care has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Radius Residential Care's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Radius Residential Care ranks #259 out of 510 companies for EV-to-EBITDA. This places Radius Residential Care in the lower half of its industry. The industry median EV-to-EBITDA is 10.69. Radius Residential Care's value of 11.09 is 3.8% above this benchmark. Historically, Radius Residential Care's own EV-to-EBITDA has ranged from 9.45 to 26.56 over the past decade. While the company's 10-year median is 11.18 vs. the industry median of 10.69, Radius Residential Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.69, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Radius Residential Care's current EV-to-EBITDA of 11.09 is 3.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Radius Residential Care. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Radius Residential Care's current EV-to-EBITDA is 11.09, which is near median its own 10-year median of 11.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Radius Residential Care stock overvalued right now?
Based on GuruFocus' analysis, Radius Residential Care (NZSE:RAD) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$0.29, compared to a current price of NZ$0.47 — trading 60.3% above its estimated fair value. The current EV-to-EBITDA is 11.09, which is near median its 10-year median of 11.18 and 3.8% above the Healthcare Providers & Services industry median of 10.69. Radius Residential Care's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Radius Residential Care (NZSE:RAD), the current EV-to-EBITDA is 11.09 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Radius Residential Care (NZSE:RAD) Overvalued in 2026?
Based on GuruFocus' analysis, Radius Residential Care stock appears to be overvalued.
The current stock price of NZ$0.47 is trading 60.3% above its estimated GF Value™ of NZ$0.29.
GuruFocus considers Radius Residential Care to be Significantly Overvalued.
Key valuation signals for NZSE:RAD:
EV-to-EBITDA: 11.09 (near median its 10-year median of 11.18)
GF Value™: NZ$0.29 vs. price of NZ$0.47 (60.3% above fair value)
Industry Position: 3.8% above the Healthcare Providers & Services median (#259 of 510)
No single metric tells the full story. See the NZSE:RAD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Radius Residential Care Ltd is a health and aged care provider for elderly and disabled people. The company provides residential care, hospital care, dementia care, respite care, and palliative care. Additionally, the company offers Young Disabled Care services for those under 65 who require assistance with self-care, mobility, and/or communication. It has one operating segment, being the provision of aged care in New Zealand.
49GF Score
Get the complete analysis for NZSE:RAD
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:RAD has been successfully added to your 
